We are live on ! Find out more
MSACU

Medicus Sciences Acquisition Corp. Unit

Delisted

MSACU was delisted on the 6th of April, 2021.

1 hedge funds and large institutions have $2.86M invested in Medicus Sciences Acquisition Corp. Unit in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% less capital invested

Capital invested by funds: $80.5M → $2.86M (-$77.7M)

98% less funds holding

Funds holding: 401 (-39)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 39

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-39
Holders Change %
-97.5%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
1
Closed
39
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LCG
26
Luxor Capital Group
New York
-$318K -32,231 Closed
HF
27
HRT Financial
New York
-$277K -28,193 Closed
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
-$253K -25,000 Closed
Verition Fund Management
29
Verition Fund Management
Connecticut
-$247K -25,000 Closed
SSA
30
Schonfeld Strategic Advisors
New York
-$237K -24,018 Closed
LC
31
Littlejohn & Co
Connecticut
-$197K -20,000 Closed
Millennium Management
32
Millennium Management
New York
-$197K -20,000 Closed
GCIA
33
Gabelli & Co Investment Advisers
New York
-$152K -15,400 Closed
GF
34
Gabelli Funds
New York
-$144K -14,600 Closed
SMA
35
Sage Mountain Advisors
Georgia
-$140K -14,200 Closed
E
36
Ergoteles
New York
-$134K -13,580 Closed
Goldman Sachs
37
Goldman Sachs
New York
-$124K -12,600 Closed
RCM
38
Radcliffe Capital Management
Pennsylvania
-$117K -11,883 Closed
SC
39
Shay Capital
New York
-$103K -10,452 Closed
UBS Group
40
UBS Group
Switzerland
-$50K -5,043 Closed

MSACU Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Unit (MSACU) for Q2 2021, worth a combined $2.86M — down 96% from $80.5M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of MSACU and 0 opened new positions — a net loss of 39 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Adage Capital Partners, exiting entirely with an estimated $7.78M sold.

  • 1 institutional investor held Medicus Sciences Acquisition Corp. Unit (MSACU) as of Q2 2021, down from 40 in Q1 2021.
  • Funds reported $2.86M of Medicus Sciences Acquisition Corp. Unit stock for Q2 2021, down 96% quarter-over-quarter.
  • 0 funds opened new Medicus Sciences Acquisition Corp. Unit positions in Q2 2021 and 39 closed out, a net change of -39 holders.
  • The largest Medicus Sciences Acquisition Corp. Unit seller in Q2 2021 was Adage Capital Partners, an estimated $7.78M sold.

Based on aggregated 13F filings for Q2 2021.